Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical SM04554 in Male Subjects With Androgenetic Alopecia
NCT02275351Phase 2Completed
- Sponsor
- Biosplice Therapeutics
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalosirvat in androgenetic alopecia (AGA), sponsored by Biosplice Therapeutics. Started Nov 2014; status: completed.
02
Drugs
dalosirvat
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02275351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275351.